Tech Company Financing Transactions
Brainomix Funding Round
Brainomix closed a $18 million Series C funding round on 3/20/2025. Investors included Boehringer Ingelheim Venture Fund, ParkWalk Advisors and Hostplus.
Transaction Overview
Company Name
Announced On
3/20/2025
Transaction Type
Venture Equity
Amount
$18,000,000
Round
Series C
Investors
Proceeds Purpose
The company intends to use the funds to accelerate its commercial expansion into the US, where it has recently secured ten FDA clearances.
Company Information
Company Status
Private & Independent
Industry
Artificial Intelligence
Mailing Address
First Floor, Seacourt Tower West Way
Oxford, OX2 0JJ
UK
Oxford, OX2 0JJ
UK
Phone
Website
Email Address
Overview
Since launching as a spin-out from the University of Oxford, Brainomix has revolutionized medical imaging with an AI-powered platform that automates validated imaging biomarkers--improving both diagnosis and treatment decisions. Our Brainomix 360 Stroke platform is the most comprehensive stroke imaging solution available, trusted by healthcare systems worldwide to drive better patient outcomes.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michalis Papadakis
Browse more venture capital transactions:
Prev: 3/20/2025: ClearGrid venture capital transaction
Next: 3/20/2025: Carbon Arc venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC transactions reported here are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs